Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
NEW YORK, Feb. 06, 2024 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company developing medicines designed to conquer epilepsies and meaningfully improve the lives of people affected by brain disorders, today announced that management will participate in a virtual presentation at the Oppenheimer 34th Annual Healthcare Life Sciences Conference on Tuesday, February 13, 2024, at 12:40 p.m. ET.
Related news for (OVID)
- MoBot alert highlights: NASDAQ: BNAI, NASDAQ: ASNS, NASDAQ: OVID, NASDAQ: CAN, NASDAQ: CHR (10/03/25 07:00 AM)
- Ovid Therapeutics Announces Pricing of Private Placement Totaling up to $175 Million in Gross Proceeds
- 24/7 Market News Snapshot 03 October, 2025 – Ovid Therapeutics Inc. Common Stock (NASDAQ:OVID)
- MoBot alert highlights: NASDAQ: APLT, NASDAQ: APDN, NASDAQ: AQMS, NASDAQ: AUID, NASDAQ: OVID (09/26/25 02:00 PM)
- MoBot’s Stock Market Highlights – 09/26/25 01:00 PM